CureVac

Anrufen Wegbeschreibung Website Kontaktieren Sie die Universität

CureVac CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with Further information can be found at www.curevac.com.

Founded in 2000 as a spin-off from the University of Tϋbingen in Germany, CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases. Based on its proprietary technology, the Company has built a deep clinical pipeline across the areas of prophylactic vaccines, cancer therapies, antibody therapies, and the treatment of rare diseases. CureVac had its initial public offering on the New York Nasdaq in August 2020. It is headquartered in Tübingen, Germany, and employs more than 600 people at its sites in Tübingen, Frankfurt, and Boston, USA.

Adresse

Friedrich-Miescher-Straße 15
Tübingen
72076

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn CureVac etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Kontaktieren Sie Die Universität

Nachricht an CureVac senden:

Verknüpfungen

Teilen